242 related articles for article (PubMed ID: 29228205)
1. Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial.
Tang L; Platek ME; Yao S; Till C; Goodman PJ; Tangen CM; Wu Y; Platz EA; Neuhouser ML; Stanczyk FZ; Reichardt JKV; Santella RM; Hsing A; Figg WD; Lippman SM; Thompson IM; Ambrosone CB
Carcinogenesis; 2018 Feb; 39(2):125-133. PubMed ID: 29228205
[TBL] [Abstract][Full Text] [Related]
2. Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial.
Tang L; Yao S; Till C; Goodman PJ; Tangen CM; Wu Y; Kristal AR; Platz EA; Neuhouser ML; Stanczyk FZ; Reichardt JK; Santella RM; Hsing A; Hoque A; Lippman SM; Thompson IM; Ambrosone CB
Carcinogenesis; 2011 Oct; 32(10):1500-6. PubMed ID: 21771722
[TBL] [Abstract][Full Text] [Related]
3. Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial.
Winchester DA; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Xu J; Zheng SL; Thompson IM; Lucia MS; Lippman SM; Parnes HL; Isaacs WB; De Marzo AM; Drake CG; Platz EA
Prostate; 2017 Jun; 77(8):908-919. PubMed ID: 28317149
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial.
Torkko K; Till C; Tangen CM; Goodman PJ; Song X; Schenk JM; Lucia MS; Peters U; van Bokhoven A; Thompson IM; Neuhouser ML
Cancer Prev Res (Phila); 2020 Jun; 13(6):521-530. PubMed ID: 32102946
[TBL] [Abstract][Full Text] [Related]
5. Circadian genes and risk of prostate cancer in the prostate cancer prevention trial.
Chu LW; Till C; Yang B; Tangen CM; Goodman PJ; Yu K; Zhu Y; Han S; Hoque AM; Ambrosone C; Thompson I; Leach R; Hsing AW
Mol Carcinog; 2018 Mar; 57(3):462-466. PubMed ID: 29318656
[TBL] [Abstract][Full Text] [Related]
6. Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial.
Price DK; Chau CH; Till C; Goodman PJ; Leach RJ; Johnson-Pais TL; Hsing AW; Hoque A; Parnes HL; Schenk JM; Tangen CM; Thompson IM; Reichardt JK; Figg WD
Cancer; 2016 Aug; 122(15):2332-40. PubMed ID: 27164191
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of genetic variations in the androgen and estrogen metabolic pathways as risk factors for sporadic and familial prostate cancer.
Cunningham JM; Hebbring SJ; McDonnell SK; Cicek MS; Christensen GB; Wang L; Jacobsen SJ; Cerhan JR; Blute ML; Schaid DJ; Thibodeau SN
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):969-78. PubMed ID: 17507624
[TBL] [Abstract][Full Text] [Related]
8. Estrogen and progesterone-related gene variants and colorectal cancer risk in women.
Lin JH; Manson JE; Kraft P; Cochrane BB; Gunter MJ; Chlebowski RT; Zhang SM
BMC Med Genet; 2011 May; 12():78. PubMed ID: 21627810
[TBL] [Abstract][Full Text] [Related]
9. Effects of functional genetic polymorphisms in the CYP19A1 gene on prostate cancer risk and survival.
Kanda S; Tsuchiya N; Narita S; Inoue T; Huang M; Chiba S; Akihama S; Saito M; Numakura K; Tsuruta H; Satoh S; Saito S; Ohyama C; Arai Y; Ogawa O; Habuchi T
Int J Cancer; 2015 Jan; 136(1):74-82. PubMed ID: 24803183
[TBL] [Abstract][Full Text] [Related]
10. Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial.
Murtola TJ; Gurel B; Umbehr M; Lucia MS; Thompson IM; Goodman PJ; Kristal AR; Parnes HL; Lippman SM; Sutcliffe S; Peskoe SB; Barber JR; Drake CG; Nelson WG; De Marzo AM; Platz EA
Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):463-9. PubMed ID: 26715424
[TBL] [Abstract][Full Text] [Related]
11. Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens.
Cussenot O; Azzouzi AR; Nicolaiew N; Fromont G; Mangin P; Cormier L; Fournier G; Valeri A; Larre S; Thibault F; Giordanella JP; Pouchard M; Zheng Y; Hamdy FC; Cox A; Cancel-Tassin G
J Clin Oncol; 2007 Aug; 25(24):3596-602. PubMed ID: 17704407
[TBL] [Abstract][Full Text] [Related]
12. Case-only Methods Identified Genetic Loci Predicting a Subgroup of Men with Reduced Risk of High-grade Prostate Cancer by Finasteride.
Dai JY; LeBlanc M; Goodman PJ; Lucia MS; Thompson IM; Tangen CM
Cancer Prev Res (Phila); 2019 Feb; 12(2):113-120. PubMed ID: 30538099
[TBL] [Abstract][Full Text] [Related]
13. Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Chen YC; Kraft P; Bretsky P; Ketkar S; Hunter DJ; Albanes D; Altshuler D; Andriole G; Berg CD; Boeing H; Burtt N; Bueno-de-Mesquita B; Cann H; Canzian F; Chanock S; Dunning A; Feigelson HS; Freedman M; Gaziano JM; Giovannucci E; Sánchez MJ; Haiman CA; Hallmans G; Hayes RB; Henderson BE; Hirschhorn J; Kaaks R; Key TJ; Kolonel LN; LeMarchand L; Ma J; Overvad K; Palli D; Pharaoh P; Pike M; Riboli E; Rodriguez C; Setiawan VW; Stampfer M; Stram DO; Thomas G; Thun MJ; Travis RC; Virtamo J; Trichopoulou A; Wacholder S; Weinstein SJ
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1973-81. PubMed ID: 17932344
[TBL] [Abstract][Full Text] [Related]
14. Serum Retinol and Carotenoid Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial.
Nash SH; Till C; Song X; Lucia MS; Parnes HL; Thompson IM; Lippman SM; Platz EA; Schenk J
Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1507-15. PubMed ID: 26269564
[TBL] [Abstract][Full Text] [Related]
15. Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial.
Chau CH; Price DK; Till C; Goodman PJ; Chen X; Leach RJ; Johnson-Pais TL; Hsing AW; Hoque A; Tangen CM; Chu L; Parnes HL; Schenk JM; Reichardt JK; Thompson IM; Figg WD
PLoS One; 2015; 10(5):e0126672. PubMed ID: 25955319
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects.
Nyante SJ; Gammon MD; Kaufman JS; Bensen JT; Lin DY; Barnholtz-Sloan JS; Hu Y; He Q; Luo J; Millikan RC
Cancer Causes Control; 2015 Jan; 26(1):121-31. PubMed ID: 25421376
[TBL] [Abstract][Full Text] [Related]
17. Association of testicular germ cell tumor with polymorphisms in estrogen receptor and steroid metabolism genes.
Ferlin A; Ganz F; Pengo M; Selice R; Frigo AC; Foresta C
Endocr Relat Cancer; 2010 Mar; 17(1):17-25. PubMed ID: 19776291
[TBL] [Abstract][Full Text] [Related]
18. Investigation of polymorphisms in genes involved in estrogen metabolism in menstrual migraine.
Sutherland HG; Champion M; Plays A; Stuart S; Haupt LM; Frith A; MacGregor EA; Griffiths LR
Gene; 2017 Apr; 607():36-40. PubMed ID: 28089731
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of Estrogen Metabolism-Related Genes and Prostate Cancer Risk in Two Populations of African Ancestry.
Brureau L; Moningo D; Emeville E; Ferdinand S; Punga A; Lufuma S; Blanchet P; Romana M; Multigner L
PLoS One; 2016; 11(4):e0153609. PubMed ID: 27074016
[TBL] [Abstract][Full Text] [Related]
20. Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study.
Yao S; Till C; Kristal AR; Goodman PJ; Hsing AW; Tangen CM; Platz EA; Stanczyk FZ; Reichardt JK; Tang L; Neuhouser ML; Santella RM; Figg WD; Price DK; Parnes HL; Lippman SM; Thompson IM; Ambrosone CB; Hoque A
Cancer Causes Control; 2011 Aug; 22(8):1121-31. PubMed ID: 21667068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
